Principal Investigator
Lazaros Lekakis
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20250489
Clinical Trial Summary
A Phase 2, Multicenter, Open-Label Study of CC-97540 (BMS-986353), CD19-Targeted NEX-T CAR T Cells, in Participants with Active SLE (Including Lupus Nephritis) with Inadequate Response to Glucocorticoids and at Least 2 Immunosuppressants (Breakfree-SLE)
Phase
Phase II
Funding Agency/Sponsor
Industrial
Disease
Transplant/cellular therapy
Contact Information
Phone Number
305-243-2647